In conclusion, we demonstrate in this study that FOXO3a protects glioma cells against TMZ treatment by activating BNIP3-mediated mitophagy, which inhibits the nuclear translocation of AIF and DNA DSBs via inhibition of oxidative stress. The gene discussed is FOXO3; the disease is central nervous system cancer.